Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Inks Peptide Distribution Deal

NEW YORK (GenomeWeb News) – Sigma-Aldrich today said that CPC Scientific will sell the firm's PEPscreen custom peptide libraries to life science researchers and pharmaceutical companies in North America.

San Jose, Calif.-based CPC specializes in peptide synthesis and supplying GMP peptides to researchers.

Sigma said that it has developed a synthesis platform that enables high-throughput production of milligram quantities of peptides, which are ideal for making custom peptides that would be used in drug discovery efforts.

"CPC's close association with the pharmaceutical and biotechnology industry provides great opportunities for Sigma-Aldrich to further engage drug discovery researchers," said Stacey Hoge, senior product manager for Sigma-Aldrich, in a statement.

Terms of the deal were not disclosed.

In a separate announcement today, Sigma said that its SAFC Pharma business segment had commenced operations at its new 7,000-square-feet laboratory in Carlsbad, Calif. The new complex includes a dedicated PCR facility, a tissue culture lab, and a scientific team focused on quality control process development, assay development, and validation.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more